XVIVO · Xvivo Perfusion Aktiebolag · Insider Trading
Transactions in Xvivo Perfusion Aktiebolag securities by directors, senior managers and their closely associated persons, as published by the market regulator under the EU Market Abuse Regulation.
Director and related-person transactions
Source-reported director and related-person transactions, including amendments and historical rows. Not a complete insider-ownership register. Coverage is limited to captured publication days; gaps may exist between the first and last day. A verified issuer LEI includes other instruments of that issuer; an ISIN-only match covers that security. Instrument types and transaction descriptions are retained verbatim; do not sum revised, historical or derivative rows as share purchases. Publication timestamps are local source times.
| Transaction date | Person | Transaction | Instrument | Volume | Price | Status |
|---|---|---|---|---|---|---|
| 2026-07-21 | Emil Billbäck Member of the Board of Directors | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 2007 Quantity | 235.8 SEK | Current |
| 2026-07-21 | Emil Billbäck Member of the Board of Directors | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 1643 Quantity | 235.8 SEK | Current |
| 2026-03-20 | Kristoffer Nordström Chief Financial Officer (CFO) | Acquisition | Xvivo PerfusionA AB Share · SE0004840718 | 300 Quantity | 181 SEK | Current |
| 2025-12-03 | Kristoffer Nordström Chief Financial Officer (CFO) | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 250 Quantity | 169.7 SEK | Current |
| 2025-12-03 | Kristoffer Nordström Chief Financial Officer (CFO) | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 250 Quantity | 169.8 SEK | Current |
| 2025-11-18 | Lena Hagman Deputy CEO/Deputy Managing Director | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 1500 Quantity | 161 SEK | Current |
| 2025-10-24 | Erik Strömqvist Member of the Board of Directors | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 1000 Quantity | 199.3 SEK | Current |
| 2025-08-13 | Gösta Johannesson Chairman of the Board of Directors · Related person: Yes | Acquisition | Aktie Share · | 1300 Quantity | 179 SEK | Current |
| 2025-07-29 | Christoffer Björn Rosenblad Chief Executive Officer (CEO)/Managing Directory | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 2000 Quantity | 197 SEK | Current |
| 2025-07-14 | Kristoffer Nordström Chief Financial Officer (CFO) | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 20 Quantity | 214 SEK | Current |
| 2025-07-14 | Camilla Öberg Member of the Board of Directors · Related person: Yes | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 703 Quantity | 213.2 SEK | Current |
| 2025-07-11 | Kristoffer Nordström Chief Financial Officer (CFO) | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 85 Quantity | 227.8 SEK | Current |
| 2025-07-11 | Kristoffer Nordström Chief Financial Officer (CFO) | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 95 Quantity | 226.4 SEK | Current |
| 2025-07-11 | Gösta Johannesson Chairman of the Board of Directors · Related person: Yes | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 1000 Quantity | 219 SEK | Current |
| 2025-05-12 | Gösta Johannesson Chairman of the Board of Directors · Related person: Yes | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 1000 Quantity | 314 SEK | Current |
| 2025-04-28 | Lena Hagman Deputy CEO/Deputy Managing Director | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 1500 Quantity | 311 SEK | Current |
| 2024-11-25 | Christoffer Björn Rosenblad Chief Executive Officer (CEO)/Managing Directory | Disposal | Xvivo Perfusion AB Share · SE0004840718 | 2000 Quantity | 457.5 SEK | Current |
| 2024-11-20 | Christoffer Björn Rosenblad Chief Executive Officer (CEO)/Managing Directory | Disposal | Xvivo Perfusion AB Share · SE0004840718 | 1000 Quantity | 457 SEK | Current |
| 2024-11-20 | Christoffer Björn Rosenblad Chief Executive Officer (CEO)/Managing Directory | Disposal | Xvivo Perfusion AB Share · SE0004840718 | 1000 Quantity | 457 SEK | Current |
| 2024-11-20 | Christoffer Björn Rosenblad Chief Executive Officer (CEO)/Managing Directory | Disposal | Xvivo Perfusion AB Share · SE0004840718 | 100 Quantity | 457 SEK | Current |
| 2024-11-14 | Erik Strömqvist Member of the Board of Directors | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 750 Quantity | 461 SEK | Current |
| 2024-06-07 | Lars Henriksson Member of the Board of Directors | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 500 Quantity | 444 SEK | Current |
| 2024-02-29 | Kristoffer Nordström Chief Financial Officer (CFO) | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 335 Quantity | 264 SEK | Current |
| 2024-01-26 | Gösta Johannesson Chairman of the Board of Directors | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 500 Quantity | 272 SEK | Current |
| 2024-01-25 | Gösta Johannesson Chairman of the Board of Directors | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 500 Quantity | 290 SEK | Current |
| 2023-11-14 | Gösta Johannesson Chairman of the Board of Directors · Related person: Yes | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 500 Quantity | 249 SEK | Current |
| 2023-04-24 | Lars Henriksson Member of the Board of Directors | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 400 Quantity | 268 SEK | Current |
| 2022-11-02 | Gösta Johannesson Chairman of the Board of Directors | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 200 Quantity | 170 SEK | Current |
| 2022-11-01 | Gösta Johannesson Chairman of the Board of Directors | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 1000 Quantity | 166.5 SEK | Current |
| 2022-08-19 | Dag Andersson Tilk Chief Executive Officer (CEO)/Managing Directory | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 499 Quantity | 199.8 SEK | Current |
| 2022-06-01 | Dag Andersson Tilk Chief Executive Officer (CEO)/Managing Directory | Acquisition | XVIVO 2022/2025 Subcription warrant · | 20000 Quantity | 17.92 SEK | Current |
| 2022-05-31 | Christoffer Björn Rosenblad Deputy CEO/Deputy Managing Director | Acquisition | XVIVO 2022/2025 Subcription warrant · | 10000 Quantity | 17.92 SEK | Current |
| 2022-05-24 | Dag Andersson Tilk Chief Executive Officer (CEO)/Managing Directory | Disposal | XVIVO 2020/2022 Subcription warrant · | 26583 Quantity | 41.95 SEK | Current Lösen minskning lösen ökning |
| 2022-05-24 | Dag Andersson Tilk Chief Executive Officer (CEO)/Managing Directory | Exercise decrease | XVIVO 2020/2022 Subcription warrant · | 5417 Quantity | 0 SEK | Current Lösen minskning lösen ökning |
| 2022-05-24 | Dag Andersson Tilk Chief Executive Officer (CEO)/Managing Directory | Exercise increase | Xvivo Perfusion AB Share · SE0004840718 | 5417 Quantity | 205.88 SEK | Current Lösen minskning lösen ökning |
| 2022-05-24 | Kristoffer Nordström Chief Financial Officer (CFO) | Disposal | XVIVO 2020/2022 Subcription warrant · | 6646 Quantity | 41.95 SEK | Current Korrigering av felaktig benämning av "finansiellt instrument" |
| 2022-05-24 | Kristoffer Nordström Chief Financial Officer (CFO) | Exercise decrease | XVIVO 2020/2022 Subcription warrant · | 1354 Quantity | 0 SEK | Current Korrigering av felaktig benämning av "finansiellt instrument" |
| 2022-05-24 | Kristoffer Nordström Chief Financial Officer (CFO) | Exercise increase | Xvivo Perfusion AB Share · SE0004840718 | 1354 Quantity | 205.88 SEK | Current Korrigering av felaktig benämning av "finansiellt instrument" |
| 2022-05-24 | Christoffer Björn Rosenblad Deputy CEO/Deputy Managing Director | Disposal | XVIVO 2020/2022 Subcription warrant · | 13292 Quantity | 41.95 SEK | Current |
| 2022-05-24 | Christoffer Björn Rosenblad Deputy CEO/Deputy Managing Director | Exercise decrease | XVIVO 2020/2022 Subcription warrant · | 2708 Quantity | 0 SEK | Current |
| 2022-05-24 | Christoffer Björn Rosenblad Deputy CEO/Deputy Managing Director | Exercise increase | Xvivo Perfusion AB Share · SE0004840718 | 2708 Quantity | 205.88 SEK | Current |
| 2022-05-24 | Dag Andersson Tilk Chief Executive Officer (CEO)/Managing Directory | Disposal | XVIVO 2020/2022 Subcription warrant · | 26583 Quantity | 41.95 SEK | Revised Lösen minskning lösen ökning |
| 2022-05-24 | Dag Andersson Tilk Chief Executive Officer (CEO)/Managing Directory | Exercise decrease | XVIVO 2020/2022 Subcription warrant · | 5417 Quantity | 0 SEK | Revised Lösen minskning lösen ökning |
| 2022-05-24 | Dag Andersson Tilk Chief Executive Officer (CEO)/Managing Directory | Exercise increase | Xvivo Perfusion AB Subcription warrant · SE0004840718 | 5417 Quantity | 205.88 SEK | Revised Lösen minskning lösen ökning |
| 2022-05-24 | Dag Andersson Tilk Chief Executive Officer (CEO)/Managing Directory | Disposal | XVIVO 2020/2022 Subcription warrant · | 26583 Quantity | 41.95 SEK | Revised |
| 2022-05-24 | Kristoffer Nordström Chief Financial Officer (CFO) | Disposal | XVIVO 2020/2022 Subcription warrant · | 6646 Quantity | 41.95 SEK | Revised |
| 2022-05-24 | Kristoffer Nordström Chief Financial Officer (CFO) | Exercise decrease | XVIVO 2020/2022 Subcription warrant · | 1354 Quantity | 0 SEK | Revised |
| 2022-05-24 | Kristoffer Nordström Chief Financial Officer (CFO) | Exercise increase | Xvivo Perfusion AB Subcription warrant · SE0004840718 | 1354 Quantity | 205.88 SEK | Revised |
| 2021-12-21 | Lena Höglund Member of the Board of Directors | Acquisition | Xvivo Perfusion aktie Share · SE0004840718 | 1300 Quantity | 252.19 SEK | Current |
| 2021-08-30 | Dag Andersson Tilk Chief Executive Officer (CEO)/Managing Directory | Acquisition | Xvivo Perfusion AB Share · SE0004840718 | 348 Quantity | 428 SEK | Current |
3749 publication days captured; dates between 2016-07-03 and 2026-10-09 may contain gaps. Checked 2026-10-09 22:25 UTC.